SCHEMBL4635216

SCHEMBL4635216

CCOc1cccc(C(=O)CC#N)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.62
HTT P42858 2/20 0.62
HPGD P15428 4/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
ALDH1A1 P00352 4/20 0.51
KMT2A Q03164 3/20 0.51
MAPT P10636 3/20 0.51
ALOX12 P18054 2/20 0.51
KDM4E B2RXH2 1/20 0.51
MEN1 O00255 1/20 0.51
ALOX15 P16050 1/20 0.51
RECQL P46063 1/20 0.51
LMNA P02545 4/20 0.50
MAPK1 P28482 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
NR1H4 Q96RI1 1/20 0.50
RAB9A P51151 4/20 0.49
NPC1 O15118 3/20 0.49
POLB P06746 1/20 0.49
CASP3 P42574 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16084813 0.87 THRB (0.57) HSD17B10HTTKMT2AMEN1MAPK1
SCHEMBL30512074 0.84 CES2 (0.66) HTTSMN1; SMN2ALDH1A1KMT2AMAPT
SCHEMBL139190 0.84 CES2 (0.66) HTTSMN1; SMN2ALDH1A1KMT2AMAPT
SCHEMBL11044058 0.83 HPGD (0.56) HSD17B10HTTHPGDSMN1; SMN2ALDH1A1
SCHEMBL7913254 0.82 HPGD (0.55) HSD17B10HTTHPGDSMN1; SMN2ALDH1A1
SCHEMBL4859516 0.82 NPC1 (0.62) HSD17B10HTTHPGDALDH1A1KMT2A
SCHEMBL4633862 0.81 KMT2A (0.51) HSD17B10HTTSMN1; SMN2ALDH1A1KMT2A
SCHEMBL397191 0.81 GSK3B (0.50) HPGDSMN1; SMN2KMT2AMAPTKDM4E
SCHEMBL2379429 0.81 RAB9A (0.55) HSD17B10HTTHPGDSMN1; SMN2ALDH1A1
SCHEMBL9559962 0.81 HPGD (0.54) HSD17B10HTTHPGDSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928455-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES Bayer Healthcare, LLC (US) 2008-06-11 EP disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed
EP-0016277-B1 2-CARBONYL-3-HYDROXY-ALKENONITRILES, THEIR USE AS ANTI-ARTHRITIC AGENTS AND PROCESSES FOR THEIR PREPARATION AMERICAN CYANAMID COMPANY (US) 1981-12-02 EP disclosed
EP-0016277-A1 2-Carbonyl-3-hydroxy-alkenonitriles, their use as anti-arthritic agents and processes for their preparation AMERICAN CYANAMID COMPANY (US) 1980-10-01 EP disclosed
WO-1980000964-A1 ANTI-INFLAMMATORY AGENTS INCLUDING 2-CARBONYL-3-HYDROXY-2-ALKENONITRILES AMERICAN CYANAMID CO (US) 1980-05-15 WO disclosed
US-4173650-A ANTIARTHRITIC AGENTS AMERICAN CYANAMID COMPANY (US) 1979-11-06 US disclosed